Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$3.69B |
| 2 |
Qualcomm
QCOM
|
+$1.73B |
| 3 |
Broadcom
AVGO
|
+$1.21B |
| 4 |
Altria Group
MO
|
+$1.21B |
| 5 |
Abbott
ABT
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$2.08B |
| 2 |
Amazon
AMZN
|
+$2.06B |
| 3 |
Netflix
NFLX
|
+$1.28B |
| 4 |
Verizon
VZ
|
+$1.06B |
| 5 |
GE Aerospace
GE
|
+$972M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.35% |
| 2 | Communication Services | 14.02% |
| 3 | Technology | 13.86% |
| 4 | Consumer Discretionary | 11.76% |
| 5 | Financials | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Kimberly-Clark
KMB
$36.2B
| $868M | 0.24% |
8,239,536
-442,154
| -5% | -$45.9M |
|
102
CME Group
CME
$94.3B
| $860M | 0.24% |
5,248,575
+4,021,575
| +328% | +$657M |
|
103
Sempra
SRE
$56.2B
| $850M | 0.23% |
14,646,356
-613,854
| -4% | -$33.6M |
|
104
Autodesk
ADSK
$52.7B
| $849M | 0.23% |
6,477,377
-39,358
| -0.6% | -$5.21M |
|
105
Johnson & Johnson
JNJ
$629B
| $822M | 0.22% |
6,777,003
-747,594
| -10% | -$93.3M |
|
106
PepsiCo
PEP
$189B
| $813M | 0.22% |
7,467,887
+6,679
| +0.1% | +$690K |
|
107
Principal Financial Group
PFG
$24.4B
| $810M | 0.22% |
15,304,087
+187
| +0% | +$10.9K |
|
108
Willis Towers Watson
WTW
$31.6B
| $805M | 0.22% |
5,313,319
+237,112
| +5% | +$36.1M |
|
109
DuPont de Nemours
DD
$19.5B
| $795M | 0.22% |
4,760,508
+1,308,431
| +38% | +$219M |
|
110
Starbucks
SBUX
$124B
| $792M | 0.22% |
16,222,454
+3,079,230
| +23% | +$175M |
|
111
Exelon
EXC
$46.6B
| $778M | 0.21% |
25,598,594
-1,247,009
| -5% | -$35.7M |
|
112
Crown Castle
CCI
$31.5B
| $757M | 0.21% |
7,021,348
-2,159,990
| -24% | -$224M |
|
113
Target
TGT
$69.9B
| $756M | 0.21% |
9,932,457
+3,866
| +0% | +$285K |
|
|
WBA
114
DELISTED
Walgreens Boots Alliance
WBA
| $743M | 0.2% |
12,380,759
+4,165,400
| +51% | +$268M |
|
|
HOLX
115
DELISTED
Hologic
HOLX
| $738M | 0.2% |
18,560,364
+1,942
| +0% | +$74.7K |
|
116
Enbridge
ENB
$112B
| $735M | 0.2% |
20,558,506
-5,037,891
| -20% | -$160M |
|
117
Alcoa
AA
$13.5B
| $716M | 0.2% |
15,268,410
+8,187,158
| +116% | +$412M |
|
118
Nutrien
NTR
$32.1B
| $676M | 0.18% |
12,438,614
+187
| +0% | +$9.28K |
|
119
Aramark
ARMK
$15.9B
| $668M | 0.18% |
24,930,061
-3,106,270
| -11% | -$85.9M |
|
120
TransDigm Group
TDG
$68.3B
| $652M | 0.18% |
1,889,909
+100,354
| +6% | +$33M |
|
121
Integra LifeSciences
IART
$1.35B
| $629M | 0.17% |
9,762,894
+149,488
| +2% | +$9.26M |
|
|
SIX
122
DELISTED
Six Flags Entertainment Corp.
SIX
| $626M | 0.17% |
8,935,558
| – | – |
|
|
VISN
123
Vistance Networks Inc
VISN
$2.67B
| $619M | 0.17% |
21,202,518
-1,389,146
| -6% | -$45.7M |
|
124
Kraft Heinz
KHC
$29.1B
| $582M | 0.16% |
9,265,092
-156,693
| -2% | -$9.3M |
|
125
M&T Bank
MTB
$36.6B
| $581M | 0.16% |
3,414,107
-2,736,452
| -44% | -$490M |
|
Similar funds
Capital Research Global Investors's Q2 2018 Portfolio in Review
As of Q2 2018, Capital Research Global Investors held 476 positions worth $366B, up 4.2% from $351B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Capital Research Global Investors's Q2 2018 filing shows 33 new, 153 increased, 172 reduced and 36 closed positions. Its largest new stake was Diamondback Energy: 7,748,206 shares worth $1.02B. The largest sale was Twenty-First Century Fox, Inc. Class A, an estimated $2.08B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Communication Services and Technology.
- Capital Research Global Investors's largest Q2 2018 buy was Diamondback Energy: 7,748,206 shares worth $1.02B.
- Capital Research Global Investors added most to Meta Platforms (Facebook) in Q2 2018, an estimated $3.69B increase.
- Capital Research Global Investors's biggest Q2 2018 reduction was Twenty-First Century Fox, Inc. Class A, cutting an estimated $2.08B.
- Capital Research Global Investors fully exited Goldman Sachs in Q2 2018, selling an estimated $515M.
- Capital Research Global Investors's ten largest holdings make up 27% of its $366B portfolio in Q2 2018.
- Capital Research Global Investors opened 33 new positions and closed 36 in Q2 2018.
- Capital Research Global Investors's portfolio value rose 4.2% quarter-over-quarter to $366B.
Based on Capital Research Global Investors's 13F filing for Q2 2018, filed 14 Aug 2018.